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Abstract
Accurate and timely identiﬁcation of anaerobic bacteria is critical to successful treatment. Classic phenotypic methods for identiﬁcation
require long turnaround times and can exhibit poor species level identiﬁcation. Matrix-assisted laser desorption ionization time-of-ﬂight
mass spectrometry (MALDI-TOF MS) is an identiﬁcation method that can provide rapid identiﬁcation of anaerobes. We present a
multi-centre study assessing the clinical performance of the VITEK MS in the identiﬁcation of anaerobic bacteria. Five different test sites
analysed a collection of 651 unique anaerobic isolates comprising 11 different genera. Multiple species were included for several of the
genera. Brieﬂy, anaerobic isolates were applied directly to a well of a target plate. Matrix solution (a-cyano-4-hydroxycinnamic acid) was
added and allowed to dry. Mass spectra results were generated with the VITEK MS, and the comparative spectral analysis and organism
identiﬁcation were determined using the VITEK MS database 2.0. Results were conﬁrmed by 16S rRNA gene sequencing. Of the 651
isolates analysed, 91.2% (594/651) exhibited the correct species identiﬁcation. An additional eight isolates were correctly identiﬁed to genus
level, raising the rate of identiﬁcation to 92.5%. Genus-level identiﬁcation consisted of Actinomyces, Bacteroides and Prevotella species.
Fusobacterium nucleatum, Actinomyces neuii and Bacteroides uniformis were notable for an increased percentage of no-identiﬁcation results
compared with the other anaerobes tested. VITEK MS identiﬁcation of clinically relevant anaerobes is highly accurate and represents a
dramatic improvement over other phenotypic methods in accuracy and turnaround time.
Keywords: Anaerobe, bacterial identiﬁcation, clinical microbiology, matrix-assisted laser desorption ionization time-of-ﬂight mass
spectrometry, VITEK-MS
Original Submission: 4 April 2013; Revised Submission: 21 June 2013; Accepted: 22 June 2013
Editor: G. Greub
Article published online: 4 July 2013
Clin Microbiol Infect 2014; 20: 335–339
10.1111/1469-0691.12317
Corresponding author: O. Garner, Department of Pathology and
Laboratory Medicine, David Geffen School of Medicine at UCLA
10833 Le Conte Avenue, Los Angeles, CA 90095-1732, USA
E-mail: ogarner@mednet.ucla.edu
Introduction
Anaerobic bacteria constitute a major component of the
microbial ﬂora found within the oral cavity and the gastroin-
testinal tract. Under most conditions anaerobic bacteria have a
saprophytic relationship with the human host. However, these
same organisms are capable of causing devastating infections
and intoxications. Most anaerobic infections/intoxications
develop in areas of devitalized tissue secondary to surgical
and traumatic wounds, bites and ischaemic extremities (e.g.
arteriosclerosis and diabetes mellitus) or are acquired by
consumption of a toxin or toxin-producing organisms. Anaer-
obic infections are often polymicrobial, contributing to difﬁ-
culty in their medical management [1], so rapid species
identiﬁcation of anaerobes can be critical to successful
treatment.
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The identiﬁcation of anaerobes has classically relied upon
phenotypic assays such as Gram-staining, growth characteris-
tics and biochemical reactivity patterns. These methodologies
can be both time-consuming and laborious, hindering the
selection of appropriate therapy. Many anaerobic species are
not very biochemically active, so a large quantity of anaerobe is
necessary for successful identiﬁcation by commercially available
biochemical kits. Anaerobes typically exhibit very slow doubling
times, contributing to the extended length of time required for
correct identiﬁcation with phenotype-based methods. There-
fore, classical phenotypic anaerobic bacteriology in the clinical
laboratory exists as a conﬁrmatory science because of
extended turnaround times that can be many days long, as
opposed to being truly diagnostic [2]. Nucleic acid sequencing
provides a more reliable identiﬁcation, but is currently too
expensive, technically complex, and labour intensive for routine
identiﬁcation of all clinically isolated anaerobic bacteria.
The implementation of matrix-assisted laser desorption
ionization time-of-ﬂight mass spectrometry (MALDI-TOF MS)
in the routine clinical laboratory provides the opportunity for
inexpensive, rapid and accurate identiﬁcation of anaerobes.
Mass spectrometry uses an ionization source to charge and
separate ionized particles according to their mass-to-charge
ratio (m/z). A detector and mass analyser then determine the
relative abundance of each molecular fragment by their m/z
ratio and generate a mass spectrum. MALDI-TOF MS
produces and detects unfragmented large proteins/peptides
from whole cells that generate spectral proﬁles that are
reproducible and speciﬁc to bacterial species. These stable
mass spectral ﬁngerprints are then compared with reference
mass spectra of well-characterized strains to produce a reliable
identiﬁcation. The aim of this multi-centre study was to
evaluate the performance of the VITEK MS MALDI-TOF MS
and VITEK MS v2.0 strain database in the identiﬁcation of
clinically relevant anaerobic bacteria in a clinical microbiology
laboratory.
Materials and Methods
Clinical evaluation sites
Five clinical sites within the USA participated in the evaluation
of the VITEK MS system including the UCLA Health System
(Los Angeles, CA, USA), North Shore LIJ Hospital (Lake
Success, NY, USA), Barnes Jewish Hospital (St Louis, MO,
USA), Cleveland Clinic (Cleveland, OH, USA) and Massachu-
setts General Hospital (Boston, MA, USA). Proﬁciency testing
was performed at all of the clinical trial sites following training
on the instrumentation by a bioMerieux representative
(bioMerieux, Marcy l’Etoile, France).
Bacterial strains
In all, 339 anaerobic strains were derived from clinical
specimens collected from the ﬁve clinical sites and 312 frozen
isolates were provided by bioMerieux to expand the analysis
to include additional organisms. A total of 651 clinically
relevant anaerobic isolates were tested. Each of the ﬁve clinical
testing sites tested a subset (at least 100) of organisms
between January 2012 and August 2012. All cultures were
incubated under anaerobic conditions for a minimum of 24 h
and a maximum of 72 h after visible growth at 35°C. Frozen
isolates were subcultured twice before analysis. Anaerobic
isolates were all cultivated on Brucella blood agar plates (BBLTM,
Sparks, MD, USA).
Sample preparation
Pure cultures of anaerobic bacteria were applied to the
VITEK MS-DS target slide using a 1-lL loop. Typical
application involved more than one isolated colony because
of the small size of anaerobic isolates. A thin layer of organism
was applied to the centre of the well. One microlitre of
VITEK MS CHCA (bioMerieux) matrix solution
(a-cyano-4-hydroxycinnamic acid) was overlaid and allowed
to air dry completely. Isolates from the same plate were
selected for Gram stain analysis and subcultured for shipment
to the reference testing facility (MIDI, Inc., Newark, DE, USA)
for 16S rRNA gene sequencing analysis.
Calibration and quality control
Escherichia coli (ATCC 8739) was used for system calibration.
A fresh (18–24 h) isolate was applied to the designated wells
on the target plate. Proper spectral acquisition of the
calibrator was necessary for analysis of the other bacterial
wells. A panel of four organisms was used for positive control
strains and fresh isolates were tested by VITEK MS on each
day of testing. These organisms included Staphylococcus aureus
(ATCC 29213), Klebsiella oxytoca (ATCC 13182), Pseudomonas
aeruginosa (ATCC 10145) and Enterobacter aerogenes (ATCC
13048). The negative control consisted of 1 lL of matrix
alone.
VITEK MS organism identiﬁcation
For each target well, 100 mass spectra proﬁles were generated
within a range of 2–20 kDa. The laser frequency was 50 Hz
and was recorded in a linear positive mode. The mass proﬁles
were averaged to produce a single, composite mass spectrum.
Analysis of a composite mass spectrum for accurate identiﬁ-
cation used the VITEK MS v2.0 database. This database is not
a library of spectra, but uses a bin matrix. The mass peaks
between 2 and 20 kDa are placed into 1300 separately
analysed bins. The bin matrix consists of a table of speciﬁcity
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values for mass peaks per bin for each species that is present in
the database. The mass peaks found in the composite spectra
are compared with the bin matrix, and the peak intensity of
each mass signal allows for the calculation of a composite
score and probability for each species. A probability score
between 60% and 100% represents a high discrimination value
and a reliable identiﬁcation. A probability score that is <60% is
found in a low discrimination identiﬁcation that consists of a
list of two to four choices for an identiﬁcation match. A report
of no identiﬁcation is produced when either no match is found
for the composite spectra, or not enough spectral peaks were
obtained in the analysis. Isolates that yielded no identiﬁcation
results were re-deposited on the target plate and reanalysed.
Conﬁrmation of isolate identiﬁcation
16S rRNA gene sequencing served as the reference standard
for identiﬁcation of anaerobic bacteria and was performed at
an outside reference laboratory. Sequencing of a 527-bp region
within the 16S rRNA gene was performed using universal 16S
primers at positions 0005F and 0531R. Isolate identiﬁcation
was determined using the MicroSeq system (Applied Biosys-
tems, Foster City, CA, USA) and the SHERLOCK DNA data
analysis software (MIDI, Inc.)
Results
A total of 651 anaerobic bacterial isolates were analysed by the
VITEK MS, representing 11 genera and 26 separate species. A
total of 91.2% (594/651) of the isolates were correctly identiﬁed
to species as conﬁrmed by 16S rRNA gene sequencing (Table 1).
An additional eight isolates were identiﬁed correctly to genus,
bringing the total numberof isolates correctly identiﬁed to genus
level to 92.5% (602/651). Ten isolates gave a result of no
identiﬁcation on the ﬁrst spot but gave a correct identiﬁcation
on the repeat spot. Forty-nine of the anaerobic isolates tested
could not be identiﬁed by the VITEK MS system. Thirty-six
isolates produced a result of no identiﬁcation. The additional 13
isolates displayed results as mixed genera (Table 2).
Gram-positive isolates
Eight genera of gram-positive anaerobes (265 isolates) were
assessed by the VITEK MS system (Table 1), comprising
Actinomyces, Clostridium, Finegoldia, Mobiluncus, Parvimonas,
Peptoniphilus, Peptostreptococcus and Propionibacterium. The
VITEK MS was able to identify 91.7% to the species level
and 92.5% of the isolates to the genus level. Five of the 265
isolates were deﬁned as mixed genera identiﬁcations, whereas
15/265 (5.7%) had no identiﬁcation. Three different species of
Actinomyces were evaluated. As a genus, 74.1% (20/27) of
isolates were identiﬁed correctly to species. Actinomyces
odontolyticus showed 85.7% correct identiﬁcation to species
while Actinomyces meyeri and Actinomyces neuii showed 75% and
66.7% correct identiﬁcation to species with a concurrent
12.5% and 33.3% (one mixed genera result) no identiﬁcation,
respectively. Four different species of Clostridium were evalu-
ated. As a genus, 96.3% (104/108) of isolates were correct to
TABLE 1. Identiﬁcation of clinically relevant anaerobes by
the VITEK MS
Anaerobe isolates
(651)
Genus
level (%)
Species
level (%)
Mixed
genera
(%)
No ID
(%)
602 (92.5) 594 (91.2) 13 (2) 36 (5.5)
Gram-positive species (265) 245 (92.5) 243 (91.7) 5 (1.9) 15 (5.7)
Actinomyces meyeri (8) 7 (87.5) 6 (75) 0 1 (12.5)
Actinomyces neuii (12) 8 (66.7) 8 (66.7) 1 (8.3) 3 (25)
Actinomyces odontolyticus (7) 6 (85.7) 6 (85.7) 0 1 (14.3)
Clostridium clostridioforme (7) 7 (100) 7 (100) 0 0
Clostridium difﬁcile (30) 27 (90) 27 (90) 0 3 (10)
Clostridium perfringens (61) 60 (98.4) 60 (98.4) 1 (1.6) 0
Clostridium ramosum (10) 10 (100) 10 (100) 0 0
Finegoldia magna (24) 23 (95.8) 23 (95.8) 0 1 (4.2)
Mobiluncus curtisii (4) 3 (75) 3 (75) 1 (25) 0
Parvimonas micra (10) 10 (100) 10 (100) 0 0
Peptoniphilus
asaccharolyticus (4)
4 (100) 4 (100) 0 0
Peptostreptococcus
anaerobius (36)
36 (100) 36 (100) 0 0
Propionibacterium acnes (52) 44 (84.6) 43 (82.7) 2 (3.8) 6 (11.5)
Gram-negative species (386) 357 (92.5) 351 (90.9) 8 (2.1) 21 (5.4)
Bacteroides caccae (30) 29 (96.7) 28 (93.3) 0 1 (3.3)
Bacteroides fragilis (71) 70 (98.6) 70 (98.6) 1 (1.4) 0
Bacteroides ovatus (40) 35 (87.5) 34 (85) 2 (5) 3 (7.5)
Bacteroides thetaiotaomicron (51) 49 (96.1) 48 (94.1) 0 2 (3.9)
Bacteroides uniformis (30) 22 (73.3) 22 (73.3) 1 (3.3) 7 (23.3)
Bacteroides vulgatus (41) 40 (97.6) 40 (97.6) 1 (2.4) 0
Fusobacterium necrophorum (26) 24 (92.3) 24 (92.3) 0 2 (7.7)
Fusobacterium nucleatum (7) 3 (42.9) 3 (42.9) 1 (14.3) 3 (42.9)
Prevotella bivia (34) 34 (100) 34 (100) 0 0
Prevotella buccae (23) 23 (100) 23 (100) 0 0
Prevotella denticola (6) 6 (100) 6 (100) 0 0
Prevotella intermedia (16) 14 (87.5) 13 (81.3) 0 2 (12.5)
Prevotella melaninogenica (11) 8 (72.7) 6 (54.5) 2 (18.2) 1 (9.1)
TABLE 2. Mixed genera results for anaerobic bacteria from
the VITEK MS
16S rRNA gene
sequencing
identiﬁcation (n) VITEK MS—mixed genera results
Actinomyces neuii (1) Actinomyces neuii, Haemophilus inﬂuenzae
Bacteroides fragilis (1) Bacteroides fragilis, Shewanella algae
Bacteroides ovatus (2) Bacteroides ovatus, Citrobacter amalonaticus,
Staphylococcus auricularis, Bacteroides vulgatus,
Microbacterium paraoxydans,
Bacteroides thetaiotaomicron
Bacteroides uniformis (1) Bacteroides uniformis, Trueperella bernardiae,
Bacteroides caccae
Bacteroides vulgatus (1) Bacteroides vulgatus, Staphylococcus cohnii subsp.
urealyticus, Enterococcus casseliﬂavus
Clostridium perfringens (1) Clostridium perfringens, Aeromonas
hydrophila/caviae
Fusobacterium nucleatum (1) Fusobacterium nucleatum, Aerococcus viridans
Mobiluncus curtisii (1) Mobiluncus curtisii, Biﬁdobacterium spp.,
Vibrio alginolyticus
Prevotella melaninogenica (2) Prevotella melaninogenica, Pediococcus acidilactici,
Streptococcus gallolyticus subsp. gallolyticus,
Corynebacterium pseudodiphtheriticum,
Streptococcus constellatus
Propionibacterium acnes (1) Clostridium bifermentans, Propionibacterium acnes,
Parvimonas micra
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species. Finegoldia magna, Parvimonas micra, Peptoniphilus as-
accharolyticus and Peptostreptococcus anaerobius were all correct
to species identiﬁcation for >95%. Mobiluncus curtisii had a
species-level identiﬁcation of 75% with the remaining isolates
having a mixed genera result consisting of Biﬁdobacterium spp.
and Vibrio alginolyticus in addition to M. curtisii. Propionibacterium
acnes showed a correct to species identiﬁcation of 82.7% (43/
52). One of the Propionibacterium isolates was correct to the
genus level only. Two of the 52 isolates had mixed genera
results and consisted of Clostridium bifermentans and Parvimonas
micra as well as Propionibacterium acnes.
Gram-negative isolates
A total of 386 isolates of gram-negative anaerobes were also
evaluated by the VITEK MS system (Table 1). The isolates
tested were from three genera: Bacteroides, Fusobacterium and
Prevotella. The VITEKMS was able to identify 90.9% to species
level and 92.5% of the isolates to genus level. Eight of the 386
isolates were deﬁned as mixed-genera identiﬁcations, whereas
21/386 (5.4%) had no identiﬁcation. Six different species of
Bacteroides were evaluated. As a genus, 92% (242/263) of
isolates were identiﬁed correctly to species. An additional three
isolates were identiﬁed correctly to the genus level. Bacteroides
caccae, Bacteroides fragilis, Bacteroides thetaiotamicron and Bacte-
roides vulgatus all showed a >93% correct to species identiﬁca-
tion. Bacteroides ovatus was 85% correct to the species level
whereas Bacteroides uniformiswas only 73.3% correct to species.
A total of 26.7% (eight isolates) of B. uniformis were not
identiﬁed, including one that gave mixed genera results. Two
different species of Fusobacterium were evaluated. As a genus,
81.8% (27/33) of isolates were identiﬁed correctly to species.
Fusobacterium necrophorum showed a 92.3% correct to species
identiﬁcation whereas F. nucleatum only showed a 42.9%
correct to species identiﬁcation with a 57.1% no identiﬁcation
including one that gave mixed genera results. Five different
species of Prevotellawere evaluated. As a genus, 91.1% (82/90) of
isolates were identiﬁed correctly to species. An additional three
isolates were identiﬁed correctly to genus level. Prevotella bivia,
Prevotella buccae and Prevotella denticola all showed 100% correct
identiﬁcation to species. A total of 81.3% of Prevotella intermedia
were identiﬁed correctly to species whereas only 54.5% of
Prevotella melaninogenica were correct to species. Three strains
(27.3%) of Prevotella melaninogenica were not identiﬁed, includ-
ing two that gave mixed genera results.
Discussion
In this study, we evaluated the performance of the VITEK MS
v2.0 MALDI-TOF system in the identiﬁcation of clinically
relevant anaerobic bacteria. Overall, the performance of this
system was highly accurate (91.2% correct to species-level
identiﬁcation compared with 16S rRNA gene sequencing.) <8%
of the total tested isolates were not identiﬁed or gave mixed
genera identiﬁcation results.
Before this evaluation, most MALDI-TOF studies showed
varied rates of identiﬁcation for anaerobes. As an example,
1660 aerobic and anaerobic bacterial isolates were evaluated in
parallel using MALDI-TOF MS and conventional phenotypic
identiﬁcation tests [3]. MALDI-TOF MS correctly identiﬁed
95.4% of isolates to at least the genus level. However, the
anaerobe group contained the highest number of either no
identiﬁcations or misidentiﬁcations. MALDI-TOF MS only
identiﬁed 2 of 30 (6.7%) Bacteroides spp., 1 of 5 (20%)
Fusobacterium spp., 1 of 2 (50%) Lactobacillus spp. and 27 of 60
(45%) Propionibacterium spp. to the genus level [3]. The current
evaluation showed an increased ability for accurate identiﬁca-
tion of most of the aforementioned anaerobes, except
F. nucleatum. This species was only correctly identiﬁed 42.9%
of the time.
A separate study looked speciﬁcally at the discriminating
power of MALDI-TOF MS to identify clinical isolates of
Bacteroides. Their data showed that this technique unequivo-
cally identiﬁed 97.5% of the strains tested (270/277). The
authors also showed that the rate of detection could be
increased when previously sequenced strains were added to
the MALDI-TOF database [4]. This highlights the point that
extending database depth with the mass spectra of additional
reference strains or sequenced clinical isolates improves the
identiﬁcation capacity of the method. The VITEK MS system
was also able to identify a wide range of Bacteroides species
with correct species identiﬁcation of 92% (242/263).
In a study by La Scola et al. 544 anaerobic clinical isolates
consisting of 79 species were evaluated by MALDI-TOF MS
and 16S rRNA gene sequencing. Using MALDI-TOF MS the
authors were only able to identify 61% of the isolates. The
authors were able to conﬁrm 100% of isolates identiﬁed as
Clostridium perfringens, B. fragilis and other common Bacteroides.
In contrast, other common anaerobes such as Propionibacteri-
um species, Finegoldia magna, most Fusobacterium species and
Prevotella species were identiﬁed at levels only above 50% by
MALDI-TOF MS. The authors concluded that the poor
bacterial identiﬁcation was mostly due to insufﬁcient spectra
within the database [5]. Clearly, the VITEK MS v2.0 system
shows database improvement for these anaerobes. Prevotella
species were identiﬁed correctly at 91.1% and all but 6 of 26
species tested showed a correct to species identiﬁcation above
80%.
Additional studies looking at anaerobic identiﬁcation by
MALDI-TOF MS have shown improved results [6–13]. A study
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[14] looking at 14 different species of anaerobes showed a
100% identiﬁcation rate of 274 isolates with the VITEK-MS. In
the presented work, the VITEK-MS and VITEK MS version 2.0
databases show the highest accuracy for the identiﬁcation of
the genus and species of the tested isolates. That said, this
system still shows some areas of weakness in identiﬁcation.
A. neuii, F. nucleatum and Prevotella melaninogenica all showed a
correct to species identiﬁcation of <70%. This is either due to
difﬁculty in producing robust spectra, or to deﬁciencies in the
number of conﬁrmatory isolates found in the database. Of the
36 isolates that gave a result of no identiﬁcation, 20 produced
insufﬁcient spectra for analysis while 16 isolates had no match
in the database. As the database improves, and more
laboratories adopt MALDI-TOF MS as a method for analysis,
the percentage of correct identiﬁcations is predicted to
increase.
The strengths of this study include the inclusion of a large
number of isolates for most of the tested species. These isolates
come from a broad geographic range within the USA, repre-
sented by the ﬁve clinical testing sites. This variability demon-
strates the breadth of spectra representing each species found
within the VITEK MS database. This study is notably limited by
the lack of some very important, clinically relevant anaerobes
including members of the genera Porphyromonas, Bilophila,
Eggerthella and an expanded list of Clostridium including Clostrid-
ium innocuum, Clostridium septicum and Clostridium novyi. Schmitt
et al. [15] recently showed that MALDI-TOF is an accurate
system for a broad array of anaerobes, even though the isolate
numbers per species found in this paper were very low.
The VITEK-MS tests is an accurate system for identifying
clinically relevant anaerobic bacteria. The implementation of
this technology in the clinical microbiology laboratory will lead
to decreased turnaround times for identiﬁcation. MALDI-TOF
MS can also be used in addition to traditional methods (colony
morphology and Gram stain) for organisms that are difﬁcult to
identify. This represents a signiﬁcant shift in the laboratory
diagnosis of anaerobic bacterial infections and will allow
improved patient care.
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